[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
- Resource Type
- Article
- Source
- The Lancet; February-March 2021, Vol. 397 Issue: 10276 p797-804, 8p
- Subject
- Language
- ISSN
- 01406736; 1474547X